Use of Palivizumab Prophylaxis to Prevent Hospitalization from Severe RSV Infection

The Office of MaineCare Services (OMS), in coordination with their Pharmacy Benefits Manager Change Healthcare (CHC), review data from the National Respiratory and Enteric Virus Surveillance System (NREVSS) to track the epidemic season for Respiratory Syncytial Virus (RSV). Palivizumab is indicated for the prevention of serious lower respiratory tract disease caused by RSV in infants. Peak RSV activity typically occurs between November and March.

Use of Palivizumab Prophylaxis to Prevent Hospitalization from Severe RSV Infection

The Office of MaineCare Services (OMS), in coordination with their Pharmacy Benefits Manager Change Healthcare (CHC), review data from the National Respiratory and Enteric Virus Surveillance System (NREVSS) to track the epidemic season for Respiratory Syncytial Virus (RSV). Palivizumab is indicated for the prevention of serious lower respiratory tract disease caused by RSV in infants. Peak RSV activity typically occurs between November and March.

HIV Testing for Older Adults

Almost 25% of all new HIV diagnoses are in people ages 45 and older. Older HIV patients have the same risk factors as any age including the following:

  • vaginal or anal sex without a condom or without Pre-exposure Prophylaxis (PreP)
  • sharing needles.

Age can make people more prone to HIV. For example, thinning vaginal walls make tears more likely and older people may also be less likely to use a condom since pregnancy is not a concern.

Reminder: Primary Care Plus (PCPlus) Application is Open

MaineCare Services is pleased to announce that we are now accepting applications for participation in MaineCare’s PCPlus program. PCPlus is a MaineCare primary care model that gives Primary Care Providers (PCPs) greater flexibility and incentives to meet MaineCare members’ healthcare needs by transitioning away from a volume-based (fee-for-service) payment system toward population-based payments tied to cost and quality-related outcomes.

Subscribe to